SINGULAR GENOMICS SYSTEMS IN (OMIC)
US82933R1005 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -94.82M | -90.88M | -98.77M | -27.95M | -12.32M | |||
| Depreciation Amortization | 3.51M | 2.43M | 1.13M | 640.00K | 350.00K | |||
| Change In Working Capital | -2.25M | -16.82M | -2.91M | 860.00K | 420.00K | |||
| Interest Paid | 941.00K | 560.00K | 570.00K | 460.00K | 10.00K | |||
| Other non cash items | 19.91M | 18.17M | 48.85M | 1.58M | 160.00K | |||
| OPERATING CASH FLOW | -73.65M | -87.09M | -51.70M | -24.87M | -11.40M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -970.00K | -6.02M | -4.86M | -1.38M | -800.00K | |||
| Other Investing Activity | 14.78M | -33.54M | -126.00M | 25.39M | -30.70M | |||
| INVESTING CASH FLOW | 13.81M | -39.57M | -130.86M | 24.01M | -31.50M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 130.60M | 7.50M | 2.46M | |||
| Stock Issued/Repurchased | 696.00K | 900.00K | 241.53M | 20.00K | 44.84M | |||
| FINANCING CASH FLOW | 696.00K | 900.00K | 372.13M | 7.52M | 47.30M | |||
| CHANGE IN CASH | -59.14M | -125.76M | 189.57M | 6.66M | 4.40M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -73.65M | -87.09M | -51.70M | -24.87M | -11.40M | |||
| Capital Expenditure | -970.00K | -6.02M | -4.86M | -1.38M | -800.00K | |||
| FREE CASH FLOW | -74.62M | -93.11M | -56.56M | -26.25M | -12.20M | |||
All data in USD